GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve 1. the Unaudited Financial Results (Standalone) along with Limited Review Report of the Statutory Auditor thereon of the Company for the 2nd quarter and half year ended on September 30 2024; 2. the declaration of Interim dividend for the Financial Year 2024-25 if any on the equity share capital of the company.